XWELL Price to Sales Ratio 2012-2026 | XWEL
Historical PS ratio values for XWELL (XWEL) over the last 10 years. The current P/S ratio for XWELL as of June 08, 2026 is .
| XWELL P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-09 | 1.07 | 0.22 | |
| 2026-03-31 | 1.15 | $4.88 | 0.24 |
| 2025-12-31 | 0.46 | $5.32 | 0.09 |
| 2025-09-30 | 0.99 | $5.65 | 0.18 |
| 2025-06-30 | 0.92 | $6.12 | 0.15 |
| 2025-03-31 | 1.02 | $6.92 | 0.15 |
| 2024-12-31 | 1.51 | $7.67 | 0.20 |
| 2024-09-30 | 1.73 | $7.83 | 0.22 |
| 2024-06-30 | 1.80 | $7.87 | 0.23 |
| 2024-03-31 | 1.69 | $7.61 | 0.22 |
| 2023-12-31 | 1.74 | $7.22 | 0.24 |
| 2023-09-30 | 2.25 | $7.06 | 0.32 |
| 2023-06-30 | 4.00 | $7.54 | 0.53 |
| 2023-03-31 | 7.20 | $8.43 | 0.85 |
| 2022-12-31 | 7.20 | $11.47 | 0.63 |
| 2022-09-30 | 15.40 | $15.44 | 1.00 |
| 2022-06-30 | 13.80 | $18.23 | 0.76 |
| 2022-03-31 | 22.60 | $17.10 | 1.32 |
| 2021-12-31 | 40.40 | $14.05 | 2.88 |
| 2021-09-30 | 29.40 | $8.61 | 3.42 |
| 2021-06-30 | 30.80 | $3.62 | 8.51 |
| 2021-03-31 | 36.80 | $1.97 | 18.69 |
| 2020-12-31 | 23.80 | $24.88 | 0.96 |
| 2020-09-30 | 39.40 | $157.49 | 0.25 |
| 2020-06-30 | 83.80 | $244.56 | 0.34 |
| 2020-03-31 | 11.40 | $636.83 | 0.02 |
| 2019-12-31 | 40.20 | $1,008.03 | 0.04 |
| 2019-09-30 | 86.40 | $1,351.89 | 0.06 |
| 2019-06-30 | 116.40 | $1,812.29 | 0.06 |
| 2019-03-31 | 144.00 | $2,002.00 | 0.07 |
| 2018-12-31 | 192.00 | $2,197.76 | 0.09 |
| 2018-09-30 | 180.00 | $2,364.16 | 0.08 |
| 2018-06-30 | 348.00 | $2,456.02 | 0.14 |
| 2018-03-31 | 864.00 | $2,676.88 | 0.32 |
| 2017-12-31 | 1644.00 | $2,791.32 | 0.59 |
| 2017-09-30 | 1668.00 | $1,790.45 | 0.93 |
| 2017-06-30 | 1980.00 | $1,391.44 | 1.42 |
| 2017-03-31 | 2604.00 | $1,496.52 | 1.74 |
| 2016-12-31 | 2556.00 | $963.75 | 2.65 |
| 2016-09-30 | 3228.00 | $3,973.02 | 0.81 |
| 2016-06-30 | 2268.00 | $3,732.63 | 0.61 |
| 2016-03-31 | 1968.00 | $2,824.63 | 0.70 |
| 2015-12-31 | 2964.00 | $2,670.64 | 1.11 |
| 2015-09-30 | 6720.00 | $49.23 | 136.50 |
| 2015-06-30 | 6720.00 | $68.71 | 97.80 |
| 2015-03-31 | 7800.00 | $176.82 | 44.11 |
| 2014-12-31 | 6600.00 | $192.80 | 34.23 |
| 2014-09-30 | 11400.00 | $162.80 | 70.02 |
| 2014-06-30 | 41040.00 | $143.32 | 286.35 |
| 2014-03-31 | 41640.00 | $194.63 | 213.94 |
| 2013-12-31 | 35520.00 | $159.42 | 222.81 |
| 2013-09-30 | 34440.00 | $111.99 | 307.52 |
| 2013-06-30 | 38040.00 | $166.28 | 228.77 |
| 2013-03-31 | 38040.00 | $6.86 | 5547.50 |
| 2012-12-31 | 34440.00 | $6.86 | 5022.50 |
| 2012-09-30 | 34800.00 | $54.29 | 641.05 |
| 2012-06-30 | 46320.00 | 0 | 0.00 |
| 2012-03-31 | 19800.00 | $454.00 | 43.61 |
| 2011-12-31 | 11880.00 | $748.00 | 15.88 |
| 2011-09-30 | 17040.00 | $1,024.67 | 16.63 |
| 2011-06-30 | 14640.00 | $1,132.67 | 12.93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.029B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |